Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
lung cancer
May 19, 2024, 10:12 |
Insight
Erman Akkus: Is oncologic treatment of very advanced disease associated with improved survival?
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X: “Is oncologic treatment…
May 19, 2024, 07:02 |
Blog
Stanley Ozogbo: At the 35th Annual NEOMED Regional Scholarship Day
Stanley Ozogbo, Resident Physician at Mercy Health, shared on X: "At the 35th Annual NEOMED…
May 19, 2024, 05:13 |
Blog
Estela Rodriguez: Join us for this Panel Discussion on Careers in Oncology Academia during ASCO24
Estela Rodriguez shared on X: "Why are we smiling? Because we like our jobs in…
May 19, 2024, 05:07 |
Drugs
First prospective phase 2 study to directly compare two anti-PD-1 antibodies as first-line treatment in advanced NSCLC - Top Science
Top Science shared on X: “This is the first prospective phase 2 study to directly…
May 18, 2024, 10:01 |
Blog
Herbert Loong: We are thrilled to have our new dean Philip Chiu visit our small department of clinical oncology
Herbert Loong shared on X/Twitter: ''We are thrilled to have our new Dean of CUHK Medicine,…
May 18, 2024, 09:06 |
Blog
Jarushka Naidoo: Perioperative Nivolumab in Stage IIA-IIIB NSCLC
Jarushka Naidoo shared on X/Twitter: ''Ph III CM77T trial at NEJM: Perioperative Nivolumab in Stage…
May 18, 2024, 08:33 |
Blog
Rami Manochakian: Results of Checkmate 77T trial of
Rami Manochakian shared a post on X/Twitter: ''Hot Off The Press. Just published at NEJM.…
May 18, 2024, 02:46 |
Drugs
Vivek Subbiah: US FDA granted accelerated approval to tarlatamab-dlle
Vivek Subbiah shared on X: "New FDA Approval. Today the US FDA granted accelerated approval…
May 17, 2024, 17:53 |
Insight
Piotr Wysocki: Better responses to immunotherapy in NSCLC patients with rare EGFR mutation
Piotr Wysocki recently posted on LinkedIn: "The efficacy of immune checkpoint inhibitors (ICI) as monotherapy in…
May 17, 2024, 14:57 |
Blog
David Gandara: LALCA-Some of my favorite all time conferences!!
David Gandara, Co-Director at Center for Experimental Therapeutics, UC Davis Comprehensive Cancer Center and Luis E.…
116
117
118
119
120
All:
1587
Posts:
1171 - 1180
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
MASCC24 Highlights: The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Highlights on the U.S. - India Cancer Moonshot Dialogue
Facebook
RSS Feed
Twitter
Linkedin
Youtube